Kenji Hikosaka

Dr. Kenji Hikosaka


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2019 in Genes
Verified
Journal Article
Open access
PDF file
MMMakoto Matsubayashi
Makoto Matsubayashi
DIDaniel Inaoka
Daniel Inaoka
KKKeisuke Komatsuya
Keisuke Komatsuya
THTakeshi Hatta
Takeshi Hatta
FKFumiya Kawahara
Fumiya Kawahara
KKKiyoshi Kita
Kiyoshi Kita
Eimeria tenella is an intracellular apicomplexan parasite, which infects cecal epithelial cells from chickens and causes hemorrhagic diarrhea and eventual death. We have previously reported the comparative RNA sequence analysis of the E. tenella sporozoite stage between virulent and precocious strains and showed that the expression of several genes involved in mitochondrial electron transport chain (ETC), such as type II NADH dehydrogenase (NDH-2), complex II (succinate:quinone oxidoreductase), malate:quinone oxidoreductase (MQO), and glycerol-3-phosphate dehydrogenase (G3PDH), were upregulated in virulent strain. To study E. tenella mitochondrial ETC in detail, we developed a reproducible method for preparation of mitochondria-rich fraction from sporozoites, which maintained high specific activities of dehydrogenases, such as NDH-2 followed by G3PDH, MQO, complex II, and dihydroorotate dehydrogenase (DHODH). Of particular importance, we showed that E. tenella sporozoite mitochondria possess an intrinsic ability to perform fumarate respiration (via complex II) in addition to the classical oxygen respiration (via complexes III and IV). Further analysis by high-resolution clear native electrophoresis, activity staining, and nano-liquid chromatography tandem-mass spectrometry (nano-LC-MS/MS) provided evidence of a mitochondrial complex II-III-IV supercomplex. Our analysis suggests that complex II from E. tenella has biochemical features distinct to known orthologues and is a potential target for the development of new anticoccidian drugs.

21 July 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
KKkeisuke komatsuya
keisuke komatsuya
TSTakaya Sakura
Takaya Sakura
KSKazuro Shiomi
Kazuro Shiomi
SŌSatoshi Ōmura
Satoshi Ōmura
KHKenji Hikosaka
Kenji Hikosaka
DIDaniel Inaoka
Daniel Inaoka
Plasmodium falciparum contains several mitochondrial electron transport chain (ETC) dehydrogenases shuttling electrons from the respective substrates to the ubiquinone pool, from which electrons are consecutively transferred to complex III, complex IV, and finally to the molecular oxygen. The antimalarial drug atovaquone inhibits complex III and validates this parasite’s ETC as an attractive target for chemotherapy. Among the ETC dehydrogenases from P. falciparum, dihydroorotate dehydrogenase, an essential enzyme used in de novo pyrimidine biosynthesis, and complex III are the two enzymes that have been characterized and validated as drug targets in the blood-stage parasite, while complex II has been shown to be essential for parasite survival in the mosquito stage; therefore, these enzymes and complex II are considered candidate drug targets for blocking parasite transmission. In this study, we identified siccanin as the first (to our knowledge) nanomolar inhibitor of the P. falciparum complex II. Moreover, we demonstrated that siccanin also inhibits complex III in the low-micromolar range. Siccanin did not inhibit the corresponding complexes from mammalian mitochondria even at high concentrations. Siccanin inhibited the growth of P. falciparum with IC50 of 8.4 μM. However, the growth inhibition of the P. falciparum blood stage did not correlate with ETC inhibition, as demonstrated by lack of resistance to siccanin in the yDHODH-3D7 (EC50 = 10.26 μM) and Dd2-ELQ300 strains (EC50 = 18.70 μM), suggesting a third mechanism of action that is unrelated to mitochondrial ETC inhibition. Hence, siccanin has at least a dual mechanism of action, being the first potent and selective inhibitor of P. falciparum complexes II and III over mammalian enzymes and so is a potential candidate for the development of a new class of antimalarial drugs.

1 November 2017 in Immunobiology
Verified
Journal Article
Closed access
TKTakane Kikuchi-Ueda
Takane Kikuchi-Ueda
GKGo Kamoshida
Go Kamoshida
TUTsuneyuki Ubagai
Tsuneyuki Ubagai
RNRyuichi Nakano
Ryuichi Nakano
ANAkiyo Nakano
Akiyo Nakano
YOYasuo Ono
Yasuo Ono

2 December 2015
Verified
Book Chapter
Open access
PDF file
KHKenji Hikosaka
Kenji Hikosaka
KKKeisuke Komatsuya
Keisuke Komatsuya
SSShigeo Suzuki
Shigeo Suzuki
KKKiyoshi Kita
Kiyoshi Kita
Mitochondria are organelle, which is found in most eukaryotic cells, and play an important roll in production of many biosynthetic intermediates as well as energy transduction. Recently, it has been reported that mitochondria contribute to cellular stress responses such as apoptosis and autophagy. These functions of mitochondria are known to be essential for survival and maintenance of homeostasis. The mitochondria of malaria parasites are quite different from those of their vertebrate hosts. Because these differences markedly contribute to drug selectivity, we have focused on the Plasmodium mitochondrion to develop antimalarial drugs. Here we summarize recent advances in our knowledge of the mitochondria of malaria parasites and discuss future prospective antimalarial drugs targeting the parasite mitochondrion.

19 September 2022 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
YHYui Honjo
Yui Honjo
SFShinya Fukumoto
Shinya Fukumoto
HSHirokazu Sakamoto
Hirokazu Sakamoto
KHKenji Hikosaka
Kenji Hikosaka

15 January 2025 in Cells
Verified
Journal Article
Open access
PDF file
XLXiaoxia X. Lin
Xiaoxia X. Lin
YBYun D. Bai
Yun D. Bai
SWSichang T. Wang
Sichang T. Wang
ANAkira Nozawa
Akira Nozawa
TSTatsuya Sawasaki
Tatsuya Sawasaki
HSHirokazu Sakamoto
Hirokazu Sakamoto
The autophagy-related ubiquitin-like conjugation systems, the ATG8 and ATG12 systems, are universally conserved in eukaryotes. However, the covalent bond in the ATG12 system has recently been shown to be evolutionarily lost in Apicomplexa. Here, we show that all genes associated with the ATG12 system are absent in piroplasmida, a lineage within Apicomplexa. Comparative genomics of ATGs further shows that piroplasm ATG3 has lost the region necessary for ATG12 binding. However, our in vitro functional analysis using recombinant proteins demonstrated that ATG3 retained the ability to interact with ATG8 in Babesia bovis, a model species in piroplasmida. These findings provide evidence that the ATG8 system is functional, while the ATG12 system is completely lost in the common ancestor of piroplasmida and highlight the evolutionary flexibility of the ATG12 system in Apicomplexa.